IMMU-04. DEVELOPMENT OF GPC2-DIRECTED CHIMERIC ANTIGEN RECEPTOR THERAPY FOR PEDIATRIC BRAIN TUMORS WITH IN VITRO TRANSCRIBED mRNA

The recent identification of glypican-2 (GPC2) as a cell surface oncoprotein in neuroblastoma, high grade glioma (HGG), and medulloblastoma provides the opportunity for the development of targeted immunotherapy. We hypothesized that chimeric antigen receptor (CAR) T cell therapy directed against GPC...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Foster, Jessica B, Griffin, Crystal, Stern, Allison, Brimley, Cameron, Lane, Maria, Buongervino, Samantha, Dimitrov, Dimiter S, Barrett, David M, Resnick, Adam C, Maris, John M, Bosse, Kristopher R
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2019
主題:
Immunology/Immunotherapy
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477251/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.125
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料